Published date: 11 March 2022
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
Any region
Value of contract
£29,039,000 to £72,598,000
Procurement reference
tender_265831/1050847
Published date
11 March 2022
Closing date
1 June 2022
Closing time
2pm
Contract start date
1 April 2023
Contract end date
31 March 2027
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Team Leidos, trading through "Leidos Supply Limited", and acting as Agent on behalf of the MoD, would like to make interested suppliers aware of our requirement for the Supply of Medical Pharmaceuticals Products, Provision of Dispensing Facilities and Overlabelling Service of Pre-packed Medicines. Contracts would commence during 2023 for a period of up to 4 years.
Lot 1 - The Supply of Wholesale Pharmaceutical Products including Licensed, Generics, Specials and Unlicensed Medicines. Estimated value for this lot ranges from £21,396,000 to £53,491,000. This is an estimate only.
Lot 2 - This lot is for The Supply of Dispensary and Delivery of Medical Pharmaceutical Articles and Associated Services to the UK MOD. Estimated value for this lot ranges from £4,290,000 to £10,724,000. This is an estimate only.
Lot 3 - This lot is for The Manufacture and Supply of Unlicensed (Specials) Pharmaceutical Products. Estimated value for this lot ranges from £1,075,000 to £2,688,000. This is an estimate only.
Lot 4 - This lot is for Over Labelled Pre-Packed Medicines. Estimated value for this lot ranges from £2,278,000 to £5,695,000. This is an estimate only.
This includes: Pharmaceutical products. Pharmaceutical articles. Medicinal products for the alimentary tract and metabolism. Medicinal products for the blood, blood-forming organs and the cardiovascular system. Medicinal products for dermatology and the musculoskeletal system. Medicinal products for the genitourinary system and hormones. General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. Medicinal products for the nervous system and sensory organs. Medicinal products for the respiratory system. Various medicinal products. Stomatology devices. Sun protection products. The supply, delivery and dispensing of Medical Pharmaceutical products, to include stoma & ostomy products, haematological consumables and provision of pre packed over labelling.
The estimated range of the procurement is £29,039,000 to £72,598,000 (over 4 year period) as Leidos reserve the right to:
(i) add additional scope in items to the schedule of requirement (SOR) during the life of the contract (any such items will fall within the scope of the Common Procurement Vocabulary (CPV) codes listed in the contract notice); and/or
(ii) to manage the range of items supplied under the Agreement (for instance, by de-listing slow moving or obsolescent items and/or adding new/replacement in-scope items).
Full details of the tender can be found within the tender documents at https://leidossupply.app.jaggaer.com
More information
Previous notice about this procurement
- Early engagement
- Published 22 February 2021, last edited 3 March 2021
Links
-
- https://leidos-supply.app.jaggaer.com/esop/guest/go/opportunity/detail?opportunityId=53632
- Link to eSourcing Portal
Additional text
-
The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement. The authority reserves the right to amend any condition related to security of information to reflect any changes in national law or government policy. If any contract documents are accompanied by instructions on safeguarding classified information (e.g. a security aspects letter), the authority reserves the right to amend the terms of these instructions to reflect any changes in national law or government policy, whether in respect of the applicable protective marking scheme, specific protective markings given, the aspects to which any protective marking applies, or otherwise. The link below to the Gov.uk website provides information on the Government Security Classification.
https://www.gov.uk/government/publications/government-security-classifications
About the buyer
Contact name
Jack Hunt
Address
Leidos, 8 Monarch Court
BRISTOL
BS16 7FH
England
Share this notice
Closing: 1 June 2022, 2pm
All content is available under the
